Abstract
Tetraterpenoids comprise of a large family of C 40 polyene, obtained from plants, fungi and bacteria. Their colouring properties have been employed to use as a natural colorant in the pharmaceutical industries. These exist as an attractive target of research because of their easy availability and plentiful health benefits in cardiovascular diseases, cancer, age related degenerative diseases, macular degeneration, antiatherosclerotic, anti-inflammatory, immunomodulatory properties and in HIV infection, probably due to their antioxidant properties. Formulating carotenoids in a particular dosage form is a big challenge as they possess some limitations like chemical unstability, poor bioavailability, less solubility and quick release. Due to this, numerous nanoencapsulation techniques have been developed till now to maintain their original properties. This review will highlight the phytochemical and pharmacological update on tetraterpenoids and their formulations.
Keywords: Carotenoids, lycopene, carotene, xanthophylls, nano-formulations, tetraterpenoids.
The Natural Products Journal
Title:Phytochemistry and Pharmacological Update on Tetraterpenoids
Volume: 11 Issue: 5
Author(s): Sapna Kumari*, Anju Goyal and Madhukar Garg
Affiliation:
- Chitkara College of Pharmacy, Chitkara University, Punjab,India
Keywords: Carotenoids, lycopene, carotene, xanthophylls, nano-formulations, tetraterpenoids.
Abstract: Tetraterpenoids comprise of a large family of C 40 polyene, obtained from plants, fungi and bacteria. Their colouring properties have been employed to use as a natural colorant in the pharmaceutical industries. These exist as an attractive target of research because of their easy availability and plentiful health benefits in cardiovascular diseases, cancer, age related degenerative diseases, macular degeneration, antiatherosclerotic, anti-inflammatory, immunomodulatory properties and in HIV infection, probably due to their antioxidant properties. Formulating carotenoids in a particular dosage form is a big challenge as they possess some limitations like chemical unstability, poor bioavailability, less solubility and quick release. Due to this, numerous nanoencapsulation techniques have been developed till now to maintain their original properties. This review will highlight the phytochemical and pharmacological update on tetraterpenoids and their formulations.
Export Options
About this article
Cite this article as:
Kumari Sapna *, Goyal Anju and Garg Madhukar , Phytochemistry and Pharmacological Update on Tetraterpenoids, The Natural Products Journal 2021; 11 (5) . https://dx.doi.org/10.2174/2210315510999200806154609
DOI https://dx.doi.org/10.2174/2210315510999200806154609 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Physiology and Pathophysiology of a Novel Angiotensin Receptor-binding Protein ATRAP/Agtrap
Current Pharmaceutical Design Pleiotropic Effects of Omega-3 Fatty Acids
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Resistin and Oxidative Stress in Non-Diabetic Obstructive Sleep Apnea Patients with Nocturnal Hypertension
Current Respiratory Medicine Reviews Hypertension in China: Past, Present, and Future
Current Hypertension Reviews Endothelial Progenitor Cells in Prehypertension
Current Pharmaceutical Design Atherogenesis in Renal Patients: A Model of Vascular Disease?
Current Vascular Pharmacology Statins as Antihypertensives
Recent Patents on Cardiovascular Drug Discovery An Update on the Cardiovascular Effects of Quercetin, a Plant Flavonoid
Current Nutrition & Food Science Uric Acid Metabolism in Pre-hypertension and the Metabolic Syndrome
Current Vascular Pharmacology Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside
Current Vascular Pharmacology The Crosstalk Between Insulin and Renin-Angiotensin-Aldosterone Signaling Systems and its Effect on Glucose Metabolism and Diabetes Prevention
Current Vascular Pharmacology The Effect of Polyphenol Consumption on Blood Pressure
Mini-Reviews in Medicinal Chemistry Novel Strategies to Ameliorate Radiation Injury: A Possible Role for Tetrahydrobiopterin
Current Drug Targets Microparticles as Biomarkers of Vascular Dysfunction in Metabolic Syndrome and its Individual Components
Current Vascular Pharmacology Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis
Current Pharmaceutical Biotechnology Non-dipping Status in Arterial Hypertension: An Overview
Current Vascular Pharmacology Hypertensive Heart Disease and the Role of Aldosterone Antagonists
Current Hypertension Reviews Family History and Preclinical Atherosclerosis
Current Hypertension Reviews Therapeutic Approach for Neuronal Disease by Regulating Reninangiotensin System
Current Hypertension Reviews Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients
Current Drug Targets